Neuland Laboratories, 524558, NEULANDLAB Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

663.50
41.10
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

857.11
0.23%
0.96

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.13
7.29
4.83

EBITDA CAGR (%)

10 Years
5 Years
3 Years

9.36
-2.70
-11.35

PAT CAGR (%)

10 Years
5 Years
3 Years

-
0.45
-29.66

P:E (Median)

8 Years
5 Years
3 Years

23.90
30.92
42.75

P:BV (Average)

8 Years
5 Years
3 Years

2.41
3.20
3.36

EV:EBITDA (Average)

8 Years
5 Years
3 Years

10.13
12.96
15.75

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var% Jun 18 Jun 17 Var%
Net Sales 172.66 160.23 7.76% 171.47 121.86 40.71% 168.74 129.92 29.88% 153.96 117.16 31.41%
Expenses 154.26 141.44 9.06% 155.63 112.69 38.10% 154.09 115.91 32.94% 144.98 109.09 32.90%
EBITDA 18.40 18.79 -2.08% 15.84 9.17 72.74% 14.65 14.01 4.57% 8.98 8.06 11.41%
EBIDTM 10.66% 11.73% 9.24% 7.53% 8.68% 10.78% 5.83% 6.89%
Other Income 1.33 0.29 358.62% 0.41 1.27 -67.72% 0.64 0.42 52.38% 1.11 2.56 -56.64%
Interest 4.71 4.88 -3.48% 3.00 4.56 -34.21% 4.07 4.97 -18.11% 3.88 4.51 -13.97%
Depreciation 6.93 5.61 23.53% 7.35 5.70 28.95% 5.92 5.54 6.86% 5.66 5.26 7.60%
PBT 8.09 8.59 -5.82% 5.90 0.19 3,005.26% 5.30 3.90 35.90% 0.55 0.86 -36.05%
Tax 1.36 0.54 151.85% 1.30 -0.55 - 0.90 1.50 -40.00% 0.14 0.21 -33.33%
PAT 6.73 8.05 -16.40% 4.60 0.74 521.62% 4.40 2.40 83.33% 0.41 0.65 -36.92%
PATM 3.90% 5.03% 2.68% 0.60% 2.61% 1.85% 0.27% 0.56%
EPS 5.22 8.99 -41.94% 3.57 0.82 335.37% 3.41 2.68 27.24% 0.32 0.73 -56.16%

Description Dec 18 Dec 17 Var% Sep 18 Sep 17 Var% Jun 18 Jun 17 Var% Mar 18 Mar 17 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales - 666.83 527.41 578.89 509.97 469.15 465.69 460.59 448.23 396.80 278.42 Net Sales Growth - 26.43% -8.89% 13.51% 8.70% 0.74% 1.11% 2.76% 12.96% 42.52% Cost Of Goods Sold - 366.24 238.37 262.90 253.46 243.99 246.53 269.20 284.69 249.90 161.99 Gross Profit - 300.59 289.04 315.99 256.52 225.16 219.16 191.39 163.54 146.90 116.44 GP Margin - 45.08% 54.80% 54.59% 50.30% 47.99% 47.06% 41.55% 36.49% 37.02% 41.82% Total Expenditure - 608.96 477.38 473.20 430.10 402.79 395.39 403.14 402.05 349.71 254.76 Power & Fuel Cost - 26.81 25.95 25.78 22.24 22.53 18.31 18.97 15.84 13.62 10.60 % Of Sales - 4.02% 4.92% 4.45% 4.36% 4.80% 3.93% 4.12% 3.53% 3.43% 3.81% Employee Cost - 104.47 95.73 84.92 59.89 49.16 36.26 34.88 30.78 26.06 21.91 % Of Sales - 15.67% 18.15% 14.67% 11.74% 10.48% 7.79% 7.57% 6.87% 6.57% 7.87% Manufacturing Exp. - 50.10 55.54 44.90 39.31 43.56 40.98 35.86 33.76 29.98 29.36 % Of Sales - 7.51% 10.53% 7.76% 7.71% 9.28% 8.80% 7.79% 7.53% 7.56% 10.55% General & Admin Exp. - 24.56 30.38 25.23 26.90 20.77 14.50 14.43 12.27 12.76 15.18 % Of Sales - 3.68% 5.76% 4.36% 5.27% 4.43% 3.11% 3.13% 2.74% 3.22% 5.45% Selling & Distn. Exp. - 28.01 24.91 23.14 26.41 20.31 33.64 21.35 18.89 16.06 12.58 % Of Sales - 4.20% 4.72% 4.00% 5.18% 4.33% 7.22% 4.64% 4.21% 4.05% 4.52% Miscellaneous Exp. - 8.76 6.50 6.34 1.89 2.47 5.17 8.45 5.80 1.32 12.58 % Of Sales - 1.31% 1.23% 1.10% 0.37% 0.53% 1.11% 1.83% 1.29% 0.33% 1.13% EBITDA - 57.87 50.03 105.69 79.87 66.36 70.30 57.45 46.18 47.09 23.66 EBITDA Margin - 8.68% 9.49% 18.26% 15.66% 14.14% 15.10% 12.47% 10.30% 11.87% 8.50% Other Income - 3.49 4.53 1.17 1.62 0.78 3.41 4.00 2.16 2.86 5.61 Interest - 15.66 18.92 21.08 24.47 27.35 24.55 31.33 33.27 29.84 25.67 Depreciation - 25.86 22.10 19.23 15.74 15.32 14.94 14.62 14.89 15.41 13.56 PBT - 19.84 13.54 66.55 41.28 24.48 34.22 15.50 0.18 4.70 -9.96 Tax - 3.69 1.73 20.17 14.87 8.70 7.56 1.86 -1.85 -0.37 -2.92 Tax Rate - 18.60% 12.78% 30.31% 36.02% 35.54% 22.09% 12.00% -1027.78% -7.87% 29.32% PAT - 16.14 11.81 46.38 26.41 15.78 26.67 13.64 2.03 5.07 -7.04 PAT before Minority Interest - 16.14 11.81 46.38 26.41 15.78 26.67 13.64 2.03 5.07 -7.04 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 2.42% 2.24% 8.01% 5.18% 3.36% 5.73% 2.96% 0.45% 1.28% -2.53% PAT Growth - 36.66% -74.54% 75.62% 67.36% -40.83% 95.53% 571.92% -59.96% - Unadjusted EPS - 12.83 10.59 41.58 29.73 18.47 32.16 17.84 3.36 9.39 -13.05

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales - 666.83 527.41 578.89 509.97 469.15 465.69 460.59 448.50 396.91 278.42 Net Sales Growth - 26.43% -8.89% 13.51% 8.70% 0.74% 1.11% 2.70% 13.00% 42.56% Cost Of Goods Sold - 366.24 238.37 262.90 253.46 243.99 246.53 269.20 284.69 249.90 161.99 Gross Profit - 300.59 289.04 315.99 256.52 225.16 219.16 191.39 163.81 147.01 116.44 GP Margin - 45.08% 54.80% 54.59% 50.30% 47.99% 47.06% 41.55% 36.52% 37.04% 41.82% Total Expenditure - 608.46 476.98 472.55 429.52 402.53 395.08 402.91 401.69 349.65 254.63 Power & Fuel Cost - 26.81 25.95 25.78 22.24 22.53 18.31 18.97 15.84 13.62 10.60 % Of Sales - 4.02% 4.92% 4.45% 4.36% 4.80% 3.93% 4.12% 3.53% 3.43% 3.81% Employee Cost - 110.46 102.99 92.74 65.38 51.81 41.74 40.75 35.92 29.73 24.52 % Of Sales - 16.56% 19.53% 16.02% 12.82% 11.04% 8.96% 8.85% 8.01% 7.49% 8.81% Manufacturing Exp. - 50.10 55.54 44.90 39.31 43.56 40.98 35.86 33.76 29.98 29.36 % Of Sales - 7.51% 10.53% 7.76% 7.71% 9.28% 8.80% 7.79% 7.53% 7.55% 10.55% General & Admin Exp. - 27.49 33.32 28.30 29.72 23.59 15.95 16.27 14.27 14.29 16.95 % Of Sales - 4.12% 6.32% 4.89% 5.83% 5.03% 3.43% 3.53% 3.18% 3.60% 6.09% Selling & Distn. Exp. - 18.28 14.04 11.16 17.52 14.54 26.57 13.51 11.42 10.80 8.08 % Of Sales - 2.74% 2.66% 1.93% 3.44% 3.10% 5.71% 2.93% 2.55% 2.72% 2.90% Miscellaneous Exp. - 9.08 6.77 6.78 1.89 2.52 4.99 8.35 5.79 1.32 8.08 % Of Sales - 1.36% 1.28% 1.17% 0.37% 0.54% 1.07% 1.81% 1.29% 0.33% 1.13% EBITDA - 58.37 50.43 106.34 80.45 66.62 70.61 57.68 46.81 47.26 23.79 EBITDA Margin - 8.75% 9.56% 18.37% 15.78% 14.20% 15.16% 12.52% 10.44% 11.91% 8.54% Other Income - 3.49 4.53 1.17 1.78 0.78 3.44 4.06 2.19 2.90 5.63 Interest - 15.66 18.93 21.09 24.48 27.36 24.56 31.33 33.27 29.84 25.67 Depreciation - 25.86 22.10 19.23 15.74 15.32 14.94 14.62 14.89 15.41 13.56 PBT - 20.34 13.93 67.19 42.00 24.72 34.55 15.78 0.83 4.92 -9.81 Tax - 3.90 1.87 20.32 14.92 8.79 7.80 1.96 -1.74 -0.35 -2.89 Tax Rate - 19.17% 13.42% 30.24% 35.52% 35.56% 22.58% 12.42% -209.64% -7.11% 29.46% PAT - 16.44 12.06 46.86 27.33 15.94 26.80 13.86 2.56 5.29 -6.90 PAT before Minority Interest - 16.44 12.06 46.86 27.08 15.93 26.75 13.82 2.57 5.27 -6.92 Minority Interest - 0.00 0.00 0.00 0.25 0.01 0.05 0.04 -0.01 0.02 0.02 PAT Margin - 2.47% 2.29% 8.09% 5.36% 3.40% 5.75% 3.01% 0.57% 1.33% -2.48% PAT Growth - 36.32% -74.26% 71.46% 71.46% -40.52% 93.36% 441.41% -51.61% - Unadjusted EPS - 13.06 10.81 42.01 30.76 18.67 32.33 18.14 4.24 9.76 -12.83

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 695.58 554.78 542.78 184.17 159.83 122.60 98.58 75.10 73.13 68.14 Share Capital 12.90 8.95 8.95 8.95 8.95 7.73 7.72 5.47 5.47 5.47 Total Reserves 682.68 234.98 222.97 175.22 150.87 114.87 90.87 69.61 67.66 62.67 Non-Current Liabilities 103.13 145.78 53.83 69.01 54.58 52.20 61.85 58.90 74.25 233.18 Secured Loans 60.72 103.49 29.81 33.40 21.22 8.87 26.11 55.90 71.58 233.18 Unsecured Loans 0.00 0.00 0.00 12.00 12.00 25.00 25.00 0.00 0.00 0.00 Long Term Provisions 11.74 9.87 9.28 6.85 6.38 5.14 4.71 3.85 2.67 0.00 Current Liabilities 331.19 370.38 288.24 270.16 296.76 308.46 264.23 289.58 279.97 96.33 Trade Payables 126.61 129.01 88.64 86.17 111.76 93.37 81.49 110.67 104.35 72.05 Other Current Liabilities 54.72 40.57 47.11 54.90 33.16 66.15 42.62 41.44 38.07 13.28 Short Term Borrowings 149.06 199.20 151.08 123.63 145.80 139.62 132.47 132.03 133.97 0.00 Short Term Provisions 0.80 1.59 1.41 5.47 6.04 9.33 7.65 5.43 3.59 11.01 Total Liabilities 1,129.90 1,070.94 884.85 523.34 511.17 483.26 424.66 423.58 427.35 397.65 Net Block 511.67 445.01 435.74 138.77 123.07 130.85 135.52 151.29 158.30 162.74 Gross Block 575.42 483.45 454.74 291.78 263.65 258.54 250.39 254.07 246.22 235.47 Accumulated Depreciation 63.75 38.44 19.00 153.00 140.58 127.69 114.87 102.78 87.92 72.73 Non Current Assets 676.96 624.22 510.60 210.00 196.04 196.38 198.10 202.38 209.26 200.65 Capital Work in Progress 104.47 126.09 19.60 40.48 41.47 34.56 35.69 27.15 27.26 30.25 Non Current Investment 30.37 30.37 30.36 7.55 7.67 7.64 7.64 7.67 7.67 7.67 Long Term Loans & Adv. 30.45 22.52 24.69 22.71 23.83 23.32 11.16 5.68 5.09 0.00 Other Non Current Assets 0.00 0.22 0.22 0.50 0.00 0.00 8.09 10.59 10.95 0.00 Current Assets 452.93 446.73 374.24 313.34 315.13 286.89 226.56 221.20 218.08 197.00 Current Investments 7.50 7.50 7.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 192.65 175.09 135.11 126.66 113.40 93.42 92.17 92.42 79.92 71.93 Sundry Debtors 164.02 193.92 181.11 119.11 128.85 118.59 98.50 96.41 99.57 72.83 Cash & Bank 37.35 17.05 12.04 9.04 6.49 6.68 0.28 1.78 4.45 12.77 Other Current Assets 51.41 16.24 13.44 11.99 66.39 68.19 35.61 30.59 34.14 39.49 Short Term Loans & Adv. 31.77 36.93 25.03 46.54 45.17 42.73 25.80 18.91 21.21 20.16 Net Current Assets 121.74 76.35 86.00 43.18 18.37 -21.58 -37.67 -68.38 -61.89 100.67 Total Assets 1,129.89 1,070.95 884.84 523.34 511.17 483.27 424.66 423.58 427.34 397.65

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 699.31 558.04 545.62 186.63 161.38 123.99 99.83 76.12 73.62 68.41 Share Capital 12.90 8.95 8.95 8.95 8.95 7.73 7.72 5.47 5.47 5.47 Total Reserves 686.41 238.24 225.81 177.68 152.42 116.26 92.12 70.63 68.15 62.95 Non-Current Liabilities 104.06 146.43 54.37 69.42 54.76 52.33 61.85 58.90 74.25 233.18 Secured Loans 60.72 103.49 29.81 33.40 21.22 8.87 26.11 55.90 71.58 233.18 Unsecured Loans 0.00 0.00 0.00 12.00 12.00 25.00 25.00 0.00 0.00 0.00 Long Term Provisions 11.91 9.87 9.28 6.85 6.38 5.14 4.71 3.85 2.67 0.00 Current Liabilities 326.98 366.93 285.60 268.00 295.14 306.90 262.99 288.53 279.71 96.16 Trade Payables 122.29 124.29 85.92 83.86 111.81 93.94 82.02 110.85 104.49 72.11 Other Current Liabilities 54.84 41.83 47.18 55.02 31.28 63.74 40.46 40.10 37.66 13.04 Short Term Borrowings 149.06 199.20 151.08 123.63 145.80 139.62 132.68 132.03 133.97 0.00 Short Term Provisions 0.80 1.59 1.41 5.50 6.25 9.61 7.83 5.54 3.60 11.02 Total Liabilities 1,130.35 1,071.40 885.59 524.05 511.53 483.48 424.98 423.91 427.93 398.12 Net Block 511.69 445.01 435.74 138.77 123.07 130.85 135.52 151.29 158.30 162.74 Gross Block 575.44 483.45 454.74 291.78 263.65 258.54 250.39 254.07 246.22 235.47 Accumulated Depreciation 63.75 38.44 19.00 153.00 140.58 127.69 114.87 102.78 87.92 72.73 Non Current Assets 676.88 624.20 510.54 209.87 195.76 195.93 197.66 201.92 208.83 200.37 Capital Work in Progress 104.47 126.09 19.60 40.48 41.47 34.56 35.69 27.15 27.26 30.25 Non Current Investment 30.21 30.21 30.20 7.39 7.39 7.36 7.36 7.39 7.39 7.39 Long Term Loans & Adv. 30.51 22.66 24.79 22.73 23.83 23.15 10.99 5.50 4.94 0.00 Other Non Current Assets 0.00 0.22 0.22 0.50 0.00 0.00 8.09 10.59 10.95 0.00 Current Assets 453.47 447.19 375.04 314.19 315.77 287.55 227.32 221.98 219.10 197.76 Current Investments 7.50 7.50 7.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 192.65 175.09 135.11 126.66 113.40 93.42 92.17 92.42 79.92 71.93 Sundry Debtors 164.02 193.92 181.11 119.11 128.85 118.59 98.50 96.41 99.70 72.84 Cash & Bank 37.84 17.26 12.49 9.71 6.98 7.07 1.18 2.70 5.23 13.42 Other Current Assets 51.46 16.28 13.53 12.02 66.53 68.47 35.48 30.45 34.25 39.57 Short Term Loans & Adv. 31.77 37.15 25.30 46.68 45.23 43.01 25.66 18.75 21.29 20.21 Net Current Assets 126.49 80.27 89.45 46.18 20.63 -19.35 -35.66 -66.54 -60.62 101.59 Total Assets 1,130.35 1,071.39 885.58 524.06 511.53 483.48 424.98 423.90 427.93 398.13

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 69.60 11.52 38.89 44.65 13.07 48.53 26.16 49.22 32.18 15.18 PBT 19.84 13.54 66.55 41.28 24.48 34.22 15.50 0.18 4.70 -9.96 Adjustment 38.93 40.35 43.95 33.85 36.35 34.39 42.26 44.29 41.76 36.96 Changes in Working Capital 15.92 -39.20 -55.25 -18.76 -38.74 -16.75 -30.81 5.23 -13.87 -9.81 Cash after chg. in Working capital 74.68 14.69 55.25 56.38 22.08 51.86 26.95 49.70 32.58 17.19 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -5.09 -3.17 -16.36 -11.73 -9.01 -3.33 -0.79 -0.48 -0.40 -2.02 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -77.22 -116.29 -42.11 -19.86 -14.13 -9.78 -7.22 -5.21 -8.07 -23.34 Net Fixed Assets -70.35 -135.20 -142.08 -27.14 -12.02 -7.02 -4.86 -7.74 -7.76 -23.27 Net Investments 0.00 -0.01 -30.31 0.12 -0.03 0.00 0.03 0.00 0.00 -0.21 Others -6.87 18.92 130.28 7.16 -2.08 -2.76 -2.39 2.53 -0.31 0.14 Cash from Financing Activity 11.98 104.86 -0.08 -23.62 1.15 -38.74 -20.16 -43.70 -24.25 10.31 Net Cash Inflow / Outflow 4.36 0.09 -3.30 1.18 0.08 0.00 -1.22 0.31 -0.14 2.15 Opening Cash & Equivalents 3.08 3.00 6.29 0.32 0.23 0.23 1.45 1.13 1.28 10.62 Closing Cash & Equivalent 7.44 3.08 3.00 1.49 0.32 0.23 0.23 1.45 1.13 12.77

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 69.91 11.27 38.68 44.83 13.17 48.77 25.83 49.34 32.33 15.23 PBT 20.34 13.93 67.19 42.00 24.72 34.55 15.78 0.83 4.92 -9.81 Adjustment 39.11 40.43 43.96 33.73 36.34 34.37 42.22 44.30 41.78 36.95 Changes in Working Capital 15.47 -40.02 -55.94 -19.17 -38.76 -16.82 -31.35 4.72 -13.98 -9.78 Cash after chg. in Working capital 74.91 14.35 55.20 56.56 22.30 52.11 26.65 49.85 32.72 17.35 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -5.01 -3.08 -16.52 -11.73 -9.13 -3.34 -0.82 -0.51 -0.38 -2.12 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -77.23 -116.29 -42.11 -19.86 -14.13 -9.84 -7.22 -5.21 -8.07 -23.34 Net Fixed Assets -70.35 -135.20 -142.08 -27.14 -12.02 -7.02 -4.86 -7.74 -7.76 -23.27 Net Investments 0.00 -0.01 -30.31 0.12 -0.03 0.00 0.03 0.00 0.00 -0.21 Others -6.88 18.92 130.28 7.16 -2.08 -2.82 -2.39 2.53 -0.31 0.14 Cash from Financing Activity 11.98 104.85 -0.09 -23.62 1.15 -38.96 -19.90 -43.70 -24.27 10.42 Net Cash Inflow / Outflow 4.66 -0.17 -3.51 1.35 0.19 -0.03 -1.28 0.42 -0.02 2.31 Opening Cash & Equivalents 3.29 3.44 6.97 0.81 0.62 0.65 1.93 1.51 1.53 11.11 Closing Cash & Equivalent 7.94 3.29 3.44 2.16 0.81 0.62 0.65 1.93 1.51 13.42

Financial Ratios

Consolidated /

Standalone

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 541.45 273.54 260.03 206.30 178.97 151.75 121.84 130.84 109.99 102.23 ROA 1.47% 1.21% 6.59% 5.11% 3.17% 5.87% 3.22% 0.48% 1.23% -1.83% ROE 3.44% 4.98% 22.39% 15.44% 11.25% 24.35% 15.92% 2.79% 7.31% -10.02% ROCE 3.95% 4.04% 15.94% 18.46% 15.74% 18.97% 15.55% 11.16% 11.40% 5.47% Fixed Asset Turnover 1.26 1.13 1.57 1.86 1.82 1.87 1.86 1.82 1.67 1.28 Receivable days 97.96 129.34 93.22 87.45 94.81 83.45 75.67 78.77 78.31 93.42 Inventory Days 100.64 106.98 81.29 84.66 79.24 71.34 71.66 69.27 68.97 92.40 Payable days 78.85 84.34 68.43 85.33 91.74 81.35 87.51 96.88 90.57 96.35 Cash Conversion Cycle 119.75 151.99 106.08 86.78 82.31 73.45 59.82 51.16 56.71 89.47 Total Debt/Equity 0.33 1.31 0.83 0.99 1.18 1.56 2.16 2.98 3.25 3.49 Interest Cover 2.27 1.72 4.16 2.69 1.90 2.39 1.49 1.01 1.16 0.61

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 544.35 277.21 263.23 209.07 180.72 153.48 123.40 132.65 110.74 102.65 ROA 1.49% 1.23% 6.65% 5.23% 3.20% 5.89% 3.26% 0.60% 1.28% -1.79% ROE 3.48% 5.02% 22.34% 15.64% 11.24% 24.14% 15.92% 3.49% 7.56% -9.82% ROCE 3.99% 4.07% 15.98% 18.57% 15.75% 18.99% 15.58% 11.35% 11.46% 5.52% Fixed Asset Turnover 1.26 1.13 1.57 1.86 1.82 1.87 1.86 1.82 1.67 1.28 Receivable days 97.96 129.34 93.22 87.45 94.81 83.45 75.67 78.78 78.35 93.43 Inventory Days 100.64 106.98 81.29 84.66 79.24 71.34 71.66 69.23 68.95 92.40 Payable days 76.53 82.06 67.03 85.01 92.70 82.14 88.22 97.55 91.06 97.22 Cash Conversion Cycle 122.08 154.27 107.48 87.10 81.35 72.66 59.11 50.45 56.25 88.61 Total Debt/Equity 0.33 1.30 0.82 0.98 1.17 1.55 2.13 2.93 3.23 3.47 Interest Cover 2.30 1.74 4.19 2.72 1.90 2.41 1.50 1.02 1.16 0.62

Top Investors:

malabar india fund limited

steadview capital mauritius limited

malabar value fund

abg capital

rohinton soli screwvala

ltr focus fund

sbi healthcare opportunities fund

icici prudential pharma healthcare and diaganostics (p.h.d) fund

icg q limited

infina finance private ltd

Annual Reports:

News Update:

USFDA completes inspection at Neuland Laboratories’ Hyderabad facility
24th Jun 2019, 09:37 AM

The inspection has been completed with five observations given under form 483
Read More
Neuland Laboratories - Quarterly Results
16th May 2019, 18:01 PM

Read More

Neuland Laboratories Ltd.

Pharmaceuticals & Drugs

BSE: 524558 | NSE: NEULANDLAB

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Neuland Laboratories Ltd.

Pharmaceuticals & Drugs

BSE: 524558 | NSE: NEULANDLAB

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: